Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients-authors' response

被引：0
|
作者：
Molina, I. [1 ]
Falco, V. [1 ]
Crespo, M. [1 ]
Riera, C. [2 ]
Ribera, E. [1 ]
Curran, A. [1 ]
Carrio, J. [2 ]
Diaz, M. [1 ]
del Saz, S. Villar [1 ]
Fisa, R. [2 ]
Lopez-Chejade, P. [2 ]
Ocana, I. [1 ]
Pahissa, A. [1 ]
机构：
[1] Univ Autonoma Barcelona, Hosp Univ Vall Hebron, Dept Infect Dis, E-08193 Barcelona, Spain
[2] Univ Barcelona, Fac Farm, Parasitol Lab, E-08028 Barcelona, Spain
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2008年 / 61卷 / 02期
关键词：
leishmania; AMB; chemoprophylaxis;
D O I：
10.1093/jac/dkm490
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：467 / 467
页数：1
相关论文
共 50 条
  • [31] Itraconazole as maintenance therapy for visceral leishmaniasis in HIV-infected patients
    Angarano G.
    Maggi P.
    Coppola S.L.
    Cavaliere R.L.
    [J]. European Journal of Clinical Microbiology and Infectious Diseases, 1998, 17 (5): : 365 - 367
  • [32] Itraconazole as maintenance therapy for visceral leishmaniasis in HIV-infected patients
    Angarano, G
    Maggi, P
    Coppola, SL
    Cavaliere, RL
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1998, 17 (05) : 365 - 367
  • [33] EFFICACY OF LIPOSOMAL AMPHOTERICIN-B IN THE TREATMENT OF VISCERAL LEISHMANIASIS IN PATIENTS COINFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS
    TORRECISNEROS, J
    VILLANUEVA, JL
    [J]. CLINICAL INFECTIOUS DISEASES, 1995, 20 (01) : 191 - 191
  • [34] Cutaneous manifestations of visceral leishmaniasis resistant to liposomal amphotericin B in an HIV-positive patient
    Alsina-Gibert, Merce
    Lopez-Lerma, Ingrid
    Martinez-Chamorro, Esteban
    Herrero-Mateu, Carme
    [J]. ARCHIVES OF DERMATOLOGY, 2006, 142 (06) : 787 - 789
  • [35] Case Report: Use of Liposomal Amphotericin B in Low Doses in Patients With Visceral Leishmaniasis
    Ren, Danfeng
    Cao, Wenya
    Liu, Xiaojing
    Han, Qunying
    Fan, Wanhu
    Li, Guoliang
    Xia, Han
    Zhang, Xi
    [J]. FRONTIERS IN MEDICINE, 2021, 8
  • [36] Predictors of Visceral Leishmaniasis Relapse in HIV-Infected Patients: A Systematic Review
    Cota, Glaucia F.
    de Sousa, Marcos R.
    Rabello, Ana
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2011, 5 (06):
  • [37] Visceral Leishmaniasis in HIV-Infected Patients: The Challenge of Relapse and Treatment Failure
    Cipriano, Patricia
    Miranda, Ana Claudia
    Antunes, Isabel
    Mansinho, Kamal
    [J]. ACTA MEDICA PORTUGUESA, 2017, 30 (06): : 443 - 448
  • [38] VISCERAL LEISHMANIASIS IN AN HIV-INFECTED PATIENT - CLINICAL-FEATURES AND RESPONSE TO TREATMENT
    FENSKE, S
    STELLBRINK, HJ
    ALBRECHT, H
    GRETEN, H
    [J]. KLINISCHE WOCHENSCHRIFT, 1991, 69 (17): : 793 - 796
  • [39] Liposomal amphotericin B and HIV-associated visceral leishmaniasis - Concerns about nephrotoxicity and administration schedule
    Sabbatani, S
    Manfredi, R
    Marinacci, G
    Pavoni, M
    Nafissi, M
    Chiodo, F
    [J]. CLINICAL DRUG INVESTIGATION, 2005, 25 (01) : 85 - 87
  • [40] The initial effectiveness of liposomal amphotericin B (AmBisome) and miltefosine combination for treatment of visceral leishmaniasis in HIV co-infected patients in Ethiopia: A retrospective cohort study
    Abongomera, Charles
    Diro, Ermias
    Pereira, Alan de Lima
    Buyze, Jozefien
    Stille, Kolja
    Ahmed, Fareed
    van Griensven, Johan
    Ritmeijer, Koert
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2018, 12 (05):
12345